PFKFB4 and neoplasm: Accordingly, on-going efforts are directed at understanding the relative roles of PFKFB3 and PFKFB4, and at examining the anti-tumor effects of dual Pfkfb3 and Pfkfb4 genomic deletion as well as combined PFK-158 and 5MPN administration.